DE2801417C2 - - Google Patents

Info

Publication number
DE2801417C2
DE2801417C2 DE2801417A DE2801417A DE2801417C2 DE 2801417 C2 DE2801417 C2 DE 2801417C2 DE 2801417 A DE2801417 A DE 2801417A DE 2801417 A DE2801417 A DE 2801417A DE 2801417 C2 DE2801417 C2 DE 2801417C2
Authority
DE
Germany
Prior art keywords
product
vinyl
general formula
compounds
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE2801417A
Other languages
German (de)
English (en)
Other versions
DE2801417A1 (de
Inventor
Jean Georges Le Blanc-Mesnil Fr Teutsch
Daniel La Varenne Saint-Hilaire Fr Philibert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of DE2801417A1 publication Critical patent/DE2801417A1/de
Application granted granted Critical
Publication of DE2801417C2 publication Critical patent/DE2801417C2/de
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19782801417 1977-01-13 1978-01-13 Neue 11beta-substituierte 1,3,5(10)- trienische steroidderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen Granted DE2801417A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7700859A FR2377419A1 (fr) 1977-01-13 1977-01-13 Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament

Publications (2)

Publication Number Publication Date
DE2801417A1 DE2801417A1 (de) 1978-07-20
DE2801417C2 true DE2801417C2 (US20110009641A1-20110113-C00116.png) 1992-09-17

Family

ID=9185438

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782801417 Granted DE2801417A1 (de) 1977-01-13 1978-01-13 Neue 11beta-substituierte 1,3,5(10)- trienische steroidderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen

Country Status (14)

Country Link
US (1) US4272530A (US20110009641A1-20110113-C00116.png)
JP (1) JPS5390254A (US20110009641A1-20110113-C00116.png)
BE (1) BE862870A (US20110009641A1-20110113-C00116.png)
CA (1) CA1121339A (US20110009641A1-20110113-C00116.png)
CH (1) CH630646A5 (US20110009641A1-20110113-C00116.png)
DE (1) DE2801417A1 (US20110009641A1-20110113-C00116.png)
DK (1) DK161334C (US20110009641A1-20110113-C00116.png)
FR (1) FR2377419A1 (US20110009641A1-20110113-C00116.png)
GB (1) GB1595133A (US20110009641A1-20110113-C00116.png)
HU (1) HU176154B (US20110009641A1-20110113-C00116.png)
IE (1) IE46302B1 (US20110009641A1-20110113-C00116.png)
LU (1) LU78859A1 (US20110009641A1-20110113-C00116.png)
NL (1) NL7800364A (US20110009641A1-20110113-C00116.png)
SE (1) SE435516B (US20110009641A1-20110113-C00116.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
FR2528434B1 (fr) 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
DE3625315A1 (de) * 1986-07-25 1988-01-28 Schering Ag 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3925179C2 (de) * 1988-08-22 1996-07-18 Volkswagen Ag Ansaugluftsteuersystem zum Betreiben einer Brennkraftmaschine mit Leerlaufdrehzahlregelung
DE4018168A1 (de) * 1990-06-01 1991-12-05 Schering Ag Ausgangsverbindungen fuer die herstellung von 10ss-h-steroiden und ein verfahren zur herstellung dieser ausgangsverbindungen
DE4132182A1 (de) * 1991-09-24 1993-03-25 Schering Ag 11(beta)-substituierte 14, 17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
US5427766A (en) * 1993-11-15 1995-06-27 The Dow Chemical Company Radiolabeled steroids for use in radiochemical-guided surgery
SK882003A3 (en) 2000-07-28 2003-07-01 Akzo Nobel Nv 16alpha-substituted steroid compounds, pharmaceutical composition comprising same and their use
FR2826004B1 (fr) * 2001-06-13 2008-03-28 Aventis Pharma Sa Procede de preparation de derives estrogenes
SI1624878T1 (sl) * 2003-05-22 2007-02-28 Pantarhei Bioscience Bv Uporaba sestavkov, ki obsegajo estrogensko komponento, za zdravljenje in preprecevanje muskuloskeletne bolecine
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
EP4231334A1 (en) 2020-10-15 2023-08-23 Resonac Corporation Etching gas, method for producing same, etching method, and method for producing semiconductor element
EP4231333A1 (en) 2020-10-15 2023-08-23 Resonac Corporation Etching gas, method for producing same, etching method, and method for producing semiconductor element

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337365A (en) * 1963-03-25 1967-08-22 Ibm Electrical resistance composition and method of using the same to form a resistor
US3299108A (en) * 1965-10-18 1967-01-17 Searle & Co 17alpha-alkynyl/alkenyl-13beta-alkyl-11-alkylgona-1, 3, 5 (10)-triene-3, 17beta-diols, ethers and esters thereof and intermediates thereto
US3346602A (en) * 1966-10-12 1967-10-10 Searle & Co 13beta-alkyl-11-alkylgona-1, 3, 5 (10)-trien-17-ones, ethers and esters thereof
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
US3629304A (en) * 1969-06-16 1971-12-21 Searle & Co 17alpha-alkynyl - 11beta 13beta - dialkylgona-1 3 5 (10)-triene - 3 17beta-diol 3-cycloalkyl ethers compositions and method
GB1255345A (en) * 1969-08-15 1971-12-01 Searle & Co 3-(3-OXO-11beta13beta-DIALKYL-17beta-HYDROXYGON-4-EN-17alpha-YL) PROPIONIC ACID gamma-LACTONE
US3755301A (en) * 1972-06-23 1973-08-28 Searle & Co Manufacture of 11-alkyl steroids
US3927046A (en) * 1972-12-09 1975-12-16 Akzona Inc Novel 11,11-alkylidene steroids
FR2235949B1 (US20110009641A1-20110113-C00116.png) * 1973-06-18 1978-03-17 Roussel Uclaf
NL7317358A (nl) * 1973-12-19 1975-06-23 Akzo Nv Nieuwe 11(beta)-alkylsteroiden van de oestraanreeks.

Also Published As

Publication number Publication date
JPS6257638B2 (US20110009641A1-20110113-C00116.png) 1987-12-02
DK161334C (da) 1991-12-09
IE780079L (en) 1978-07-13
NL7800364A (nl) 1978-07-17
LU78859A1 (fr) 1978-09-18
DE2801417A1 (de) 1978-07-20
GB1595133A (en) 1981-08-05
CH630646A5 (fr) 1982-06-30
US4272530A (en) 1981-06-09
CA1121339A (fr) 1982-04-06
IE46302B1 (en) 1983-04-20
JPS5390254A (en) 1978-08-08
FR2377419A1 (fr) 1978-08-11
SE435516B (sv) 1984-10-01
FR2377419B1 (US20110009641A1-20110113-C00116.png) 1979-04-20
HU176154B (en) 1980-12-28
SE7714614L (sv) 1978-07-14
DK13978A (da) 1978-07-14
BE862870A (fr) 1978-07-12
DK161334B (da) 1991-06-24

Similar Documents

Publication Publication Date Title
DE2801417C2 (US20110009641A1-20110113-C00116.png)
DE2858797C2 (US20110009641A1-20110113-C00116.png)
EP0648779B1 (de) Neue 11-Benzaldoxim-17beta methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69910068T2 (de) 17beta-acyl-17alpha-propynyl-11beta-arylsteroide und ihre derivate mit agonistischen oder antagonistischen hormonalen aktivitäten
DE1801750A1 (de) Von Prostaglandinen abgeleitete Verbindungen und Verfahren zu ihrer Herstellung
DE10236405A1 (de) Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
DE2147391C3 (de) Verfahren zur Herstellung von 13- Äthyl-17 a -äthinyl-17 ß -hydroxy- 16 a -methylgona^-en-S-on
DE2748250C2 (US20110009641A1-20110113-C00116.png)
DE1493042B2 (de) 17 Tetrahydropyranylather und 3,17 Bis (tetrahydropyranyl)-ather von Östradiol und Ostradioldenvaten, Ver fahren zu deren Herstellung und diese enthaltende Heilmittel
DE1810343A1 (de) Neue Adamantylidenverbindungen
DE1961433B2 (de) 8 Alkoxy 4 hydroxy 3 methyl 10 methylen 2,9 dioxatncyclo (4,3,1,0 hoch 3,hoch 7) decane und 8 Alkoxy 4 hydroxy 3,10 dimethyl 2,9 dioxatncyclo (4,3,1,0 hoch 3,hoch 7) decane sowie Verfahren zu ihrer Herstellung
AT269547B (de) Verfahren zur Herstellung eines konzeptionsverhindernden Mittels für warmblütige Tiere
DE2109305C3 (de) 20-Hydroxylierte 17 a - Methyl-19-nor-pregna-4,9diene, Verfahren zu deren Herstellung sowie Zwischenprodukte
DE60004007T2 (de) Ein Verfahren zur Isolierung 2-Deoxyecdysteron aus Zoanthus sp und ihre Verwendung zur Herstellung eines Medikaments zur Geburtseinleitung oder zum Schwangerschaftsabbruch
DE2741771A1 (de) Neue 2,2-dimethyl-19-nor-steroide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE1808425C (de) 3 Oxo 17beta hydroxy 17 alpha (but 2 myl> 13 beta C tief 1 bis C tief 3 alkyl gona 4,9,11 tnene
DE4216003A1 (de) Dissoziierte kompetitive Progesteronantagonisten
DE1235315B (de) Verfahren zur Herstellung von 3, 11beta, 17beta-Trihydroxy-17alpha-aethinyl-delta 1,3,5(10)-oestratrien bzw. von 3-Estern oder 3-AEthern desselben
AT251772B (de) Verfahren zur Herstellung eines neuen Äthinylderivates des 8-iso-Östrons
DE2213482A1 (de) 17alpha-Äthinylöstriol verbindungen und ihre Herstellung
AT329778B (de) Verfahren zur herstellung von neuen 17alfa-athinylostriolderivaten
AT240540B (de) Verfahren zur Herstellung von 4-Chlor-Δ<4>-3-ketosteroidverbindungen
DE1445626A1 (de) Verfahren zur Gewinnung von Alkaloiden
DE2348197A1 (de) Noraethindron-o-alkyloxime
DE1468554C (de) 20 beta tert Amino 3 alpha hydroxy (bzw acyloxy) 5 beta pregnane bzw de ren Salze sowie Verfahren zu ihrer Her stellung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: ZUMSTEIN SEN., F., DR. ASSMANN, E., DIPL.-CHEM. DR

8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 2858798

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 2858798

8125 Change of the main classification

Ipc: A61K 31/19

D2 Grant after examination
8380 Miscellaneous part iii

Free format text: SEITE 5, ZEILE 49 "ALKYLREST" AENDERN IN "ALLYLREST"

8325 Change of the main classification

Ipc: C07J 1/00

8380 Miscellaneous part iii

Free format text: DIE NEBENKLASSEN LAUTEN RICHTIG: "C07J 17/00 C07J 33/00 A61K 31/575"

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee